Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mol Cell Biol. 2000 Jun;20(12):4455-61.

Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.

Author information

  • 1Howard Hughes Medical Institute, Departments of Medicine, Microbiology and Immunology, University of California, San Francisco 94143-0703, USA.

Abstract

The regulatory factor X (RFX) complex, which contains RFXANK(B), RFXAP, and RFX5, binds to X and S boxes in major histocompatibility complex class II (MHC II) promoters. In the bare lymphocyte syndrome (BLS), which is a human severe combined immunodeficiency, MHC II promoters are neither occupied nor transcribed. Thus, the absence of any one subunit prevents the formation of the RFX complex. Nevertheless, except for a weak binding between RFX5 and RFXAP, no other interactions between RFX proteins have been described. In this study, we demonstrate that RFXANK(B) binds to RFXAP to form a scaffold for the assembly of the RFX complex, which then binds to DNA. Moreover, mutant RFXANK(B) and RFXAP proteins from complementation groups B and D of BLS, respectively, cannot support this interaction. Our data elucidate an intriguing medical situation, where a genetic disease targets two different surfaces that are required for the nucleation of a multisubunit DNA-protein complex.

PMID:
10825209
[PubMed - indexed for MEDLINE]
PMCID:
PMC85813
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk